Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CODEXIS, INC. (CDXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 SC 13G/A BlackRock Inc. reports a 10.4% stake in CODEXIS INC
08/03/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/03/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Codexis Reports Second Quarter 2023 Financial Results Company Recently Announced Enhanced Strategic Focus and Portfolio Prioritization"
07/20/2023 8-K Quarterly results
06/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Amendment to Ninth Amended and Restated Certificate of Incorporation of Codexis, Inc",
"Codexis, Inc. 2023 Employee Stock Purchase Plan",
"Amendment to the Codexis, Inc. 2019 Incentive Award Plan"
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/04/2023 8-K Quarterly results
05/04/2023 POS EX Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 144 Form 144 - Report of proposed sale of securities:
04/17/2023 144 Form 144 - Report of proposed sale of securities:
04/17/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/17/2023 4 NICOLS JOHN J (Director) has filed a Form 4 on CODEXIS, INC.
Txns: Sold 35,714 shares @ $4.0917, valued at $146.1k
Sold 35,714 shares @ $4.1071, valued at $146.7k
Exercised 35,714 options to buy @ $1.97, valued at $70.4k
Exercised 35,714 options to buy @ $1.97, valued at $70.4k
03/09/2023 4 Norrett Kevin (COO) has filed a Form 4 on CODEXIS, INC.
Txns: Granted 83,456 shares @ $0
Sold 8,596 shares @ $4.6027, valued at $39.6k
Sold 8,258 shares @ $4.5552, valued at $37.6k
03/09/2023 4 DILLY STEPHEN GEORGE (See Remarks) has filed a Form 4 on CODEXIS, INC.
Txns: Granted 289,000 shares @ $0
Sold 28,088 shares @ $4.6027, valued at $129.3k
Sold 26,987 shares @ $4.5552, valued at $122.9k
03/09/2023 4 Fitzgerald Margaret Nell (See remarks) has filed a Form 4 on CODEXIS, INC.
Txns: Granted 77,272 shares @ $0
Sold 8,000 shares @ $4.6027, valued at $36.8k
Sold 7,686 shares @ $4.5552, valued at $35k
02/27/2023 10-K Annual Report for the period ended December 31, 2022
02/27/2023 4 NICOLS JOHN J (Director) has filed a Form 4 on CODEXIS, INC.
Txns: Sold 39,785 shares @ $5.3593, valued at $213.2k
Sold 35,714 shares @ $4.8343, valued at $172.7k
Exercised 35,714 options to buy @ $1.97, valued at $70.4k
02/27/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
02/23/2023 8-K Quarterly results
Docs: "Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results Biotherapeutics Application of CodeEvolver® Validated by Recent Data Supporting the Potential for Three Upcoming Investigational New Drug Applications"
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2023 SC 13G/A Nantahala Capital Management, LLC reports a 6.8% stake in Codexis, Inc.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 4 TAYLOR DEAN ROSS JR (Advisor) has filed a Form 4 on CODEXIS, INC.
Txns: Paid exercise price by delivering 1,224 shares @ $6.51, valued at $8k
02/03/2023 8-K Quarterly results
01/25/2023 3 Ryali Sriram (CFO) has filed a Form 3 on CODEXIS, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy